Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease
NCT07448402
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
50
Enrollment
OTHER_GOV
Sponsor class
Conditions
Psoriasis
Psoriasis Arthritis
Psoriasis (PsO)
Interventions
BIOLOGICAL:
Guselkumab (GUS)
BIOLOGICAL:
Risankizumab (RISA)
Sponsor
Caja Costarricense de Seguro Social